Crocs stock gains 1.45 percent as October earnings approach

Published on 10/05/2026 at 19:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Crocs stock traded at USD 119.80 on October 5, 2026, below its USD 141.28 52-week high. The next report is scheduled for October 29 after Q2 revenue rose 2.6 percent.

CROX, US2270461096, Illustration mit AI erstellt.

Crocs (ISIN US2270461096) was trading at USD 119.80 on Nasdaq on October 5, 2026, at 1:54 p.m. ET, up 1.45 percent from the USD 118.09 prior close. According to Investing.com, the next earnings report is scheduled for October 29, 2026.

Q2 revenue rose 2.6 percent

Crocs reported USD 1.18 billion in second-quarter 2026 revenue, up 2.6 percent from the prior-year quarter, while EPS reached USD 4.55 against a USD 4.35 consensus estimate, according to MarketBeat on September 22, 2026. The revenue figure exceeded the USD 1.15 billion estimate by USD 30 million, giving the latest reported quarter a clear sales comparison.

The company also set fiscal 2026 EPS guidance at USD 13.70-14.00 and third-quarter EPS guidance at USD 3.20-3.30, MarketBeat reported. That outlook places the October report at the center of the stock story, because the market will measure new results against a full-year earnings range that is already defined.

Tariffs pressure footwear margins

Investing.com said Crocs' second-quarter adjusted gross margin fell 170 basis points to 60 percent amid tariff pressure, while operating margin declined 180 basis points to 25.1 percent. The same summary said the Crocs brand exceeded USD 1 billion in quarterly revenue for the first time, while HEYDUDE revenue declined 6 percent to USD 179 million.

The contrast matters for investors: headline revenue still grew, but cost pressure and the weaker HEYDUDE business created a more demanding test for the October results. Zacks puts the consensus estimate for third-quarter EPS at USD 3.30 and quarterly revenue at USD 1.00 billion.

Analysts see USD 139.10 target

MarketBeat reported a Moderate Buy consensus from 20 analysts on September 22, 2026, with 10 Buy ratings, one Strong Buy, seven Holds and two Sells. The average 12-month price target was USD 139.10, which lies 16.1 percent above the USD 119.80 Nasdaq price on October 5, 2026.

The consensus is constructive but not one-sided. Goldman Sachs carried a USD 95.00 Sell target in the same MarketBeat report, while UBS had a Neutral rating and a USD 120.00 target, showing how sharply analyst views differ around earnings durability and margin risk.

Stock remains below yearly high

CROX was trading at USD 119.80 on Nasdaq on October 5, 2026, with a session range of USD 117.61 to USD 120.06 and a 52-week range of USD 73.21 to USD 141.28. Its market capitalization was USD 5.7 billion and volume was 427,341 shares at 1:54 p.m. ET.